These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 1494395)
21. [About the article: "Intramuscular interferon beta-1a therapy initiated during a first demyelinating event in multiple sclerosis" by Jacobs LD et al]. Labetouelle M J Fr Ophtalmol; 2001 Feb; 24(2):222. PubMed ID: 11332406 [No Abstract] [Full Text] [Related]
22. [Corticoids and multiple sclerosis]. Defer G; Cesaro P; Degos JD Ann Med Interne (Paris); 1994 Jun; 145 Suppl 2():37-41. PubMed ID: 8074340 [No Abstract] [Full Text] [Related]
23. [Current methods of the multiple sclerosis treatment]. Kovalenko PA; Shamanskiĭ SV; Baziĭ NI Voen Med Zh; 2001 Oct; 322(10):45-52. PubMed ID: 11764483 [No Abstract] [Full Text] [Related]
27. [Intrathecal corticosteroids in multiple sclerosis. Review of the literature and personal cases]. Giunta A; Palchetti R; Tortoli V Rass Neurol Veg; 1965 Apr; 19(1):123-42. PubMed ID: 5325554 [No Abstract] [Full Text] [Related]
28. Treatment of multiple sclerosis with high-dose corticosteroids may prolong the prothrombin time to dangerous levels in patients taking warfarin. Kaufman M Mult Scler; 1997 Aug; 3(4):248-9. PubMed ID: 9372508 [TBL] [Abstract][Full Text] [Related]
29. [Copolymer 1 in therapy of multiple sclerosis]. Weilbach FX; Voltz R; Hohlfeld R; Hartung HP Nervenarzt; 1995 Jun; 66(6):473-7. PubMed ID: 7543660 [No Abstract] [Full Text] [Related]
30. The role of corticosteroids in chronic obstructive pulmonary disease. Calverley PM Semin Respir Crit Care Med; 2005 Apr; 26(2):235-45. PubMed ID: 16088440 [TBL] [Abstract][Full Text] [Related]
32. [Corticoid and ACTH therapy of neurologic diseases]. Hallen O Med Welt; 1973 Jun; 24(23):951-4. PubMed ID: 4355430 [No Abstract] [Full Text] [Related]
33. [Adverse effects of treatment with corticosteroids in pharmacological doses]. Frey H Tidsskr Nor Laegeforen; 1976 Nov; 96(31):1662-3. PubMed ID: 982403 [No Abstract] [Full Text] [Related]
34. Letter: Arachnoiditis from intrathecally given corticosteroids in the treatment of multiple sclerosis. Nelson D Arch Neurol; 1976 May; 33(5):373. PubMed ID: 946766 [No Abstract] [Full Text] [Related]
35. [Adverse effects of inhaled corticosteroids are dose-dependent]. Mäkelä M; Haahtela T Duodecim; 2003; 119(10):921-2. PubMed ID: 12833782 [No Abstract] [Full Text] [Related]
36. Corticosteroids in atrial fibrillation: Friends or foes? Korantzopoulos P Arch Intern Med; 2006 Sep; 166(16):1785. PubMed ID: 16983062 [No Abstract] [Full Text] [Related]
37. Multiple sclerosis presenting with fantastic confabulation. Gundogar D; Demirci S Gen Hosp Psychiatry; 2006; 28(5):448-51. PubMed ID: 16950386 [TBL] [Abstract][Full Text] [Related]
38. Oral rather than intravenous corticosteroids should be used to treat MS relapses - No. Bowen JD; Qian P Mult Scler; 2017 Jul; 23(8):1058-1060. PubMed ID: 28326883 [No Abstract] [Full Text] [Related]
39. Corticosteroids and atrial fibrillation: Risks or benefits? Liu T; Li G Arch Intern Med; 2006 Sep; 166(16):1785-6. PubMed ID: 16983061 [No Abstract] [Full Text] [Related]
40. [Corticosteroids. Principles and rules of use, posology]. Llorca G Rev Prat; 1996 Jan; 46(1):91-8. PubMed ID: 8596898 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]